Breakthrough Turmeric Clinical Trial: PHASE ONE Grant Fuels Hope for Less Toxic Oral Cancer Treatment Madelyn OlsenSeptember 11, 2024Grant Announcement
Breaking Barriers: PHASE ONE Funds Promising Immunotherapy Research for Metastatic Pancreatic Cancer Madelyn OlsenJune 13, 2024Grant Announcement
Promising New Combination Therapy May Pave the Way for Targeted Treatment in Non-Hodgkin Lymphoma Madelyn OlsenApril 17, 2024Grant Announcement
Revolutionizing T-cell Acute Lymphoblastic Leukemia (T-ALL) Treatment: A Novel Combination Therapy Offers New Hope Madelyn OlsenDecember 12, 2023Grant Announcement
Unlocking New Hope: PHASE ONE Funds Phase I/II Trial Investigating a Novel Approach to Pediatric Cancer Treatment for Solid Tumors Madelyn OlsenSeptember 19, 2023Grant Announcement
PHASE ONE Funds Phase II Trial Using Biomarkers to Match Metastatic ER+ Breast Cancer Patients with Effective Treatments Madelyn OlsenJuly 27, 2023Grant Announcement
PHASE ONE Funds Imerman Angels’ Clinical Trial Matching Program Madelyn OlsenApril 6, 2023Grant Announcement
Grant Announcement for Phase II Study in Multiple Myeloma at USC Megan StubbsOctober 13, 2022Grant Announcement
Grant Announcement for Study Using NK Cells to Treat Ovarian Cancer at Dana-Farber Cancer Institute Megan StubbsSeptember 26, 2022Grant Announcement
